FDA seeks to remove warnings from labels of hormone therapies for menopause

WASHINGTON, DC — The FDA is making a concerted effort to increase access to hormone replacement therapies (HRTs) for women by calling on their makers to apply to remove the boxed warnings the agency added to ...